
Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …

Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current …

